ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 156 filers reported holding ITEOS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $143,193 | -77.3% | 13,077 | -71.8% | 0.00% | -75.0% |
| Q1 2023 | $632,157 | +38.6% | 46,448 | +109.9% | 0.00% | +33.3% |
| Q2 2022 | $456,000 | -46.2% | 22,127 | -16.0% | 0.00% | -57.1% |
| Q1 2022 | $847,000 | -66.0% | 26,335 | -50.8% | 0.01% | -70.8% |
| Q4 2021 | $2,491,000 | +724.8% | 53,507 | +378.4% | 0.02% | +500.0% |
| Q3 2021 | $302,000 | -53.3% | 11,184 | -55.6% | 0.00% | -42.9% |
| Q2 2021 | $647,000 | – | 25,215 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $37,274,864 | 15.53% |
| MPM BioImpact LLC | 1,745,943 | $23,762,284 | 6.17% |
| Saturn V Capital Management LP | 480,653 | $6,541,687 | 4.89% |
| Boxer Capital, LLC | 2,154,058 | $29,317 | 1.44% |
| RA Capital Management | 4,417,259 | $60,118,895 | 1.36% |
| Octagon Capital Advisors LP | 596,000 | $8,111,560 | 1.17% |
| BVF INC/IL | 1,810,835 | $24,645,464 | 0.90% |
| AlphaCentric Advisors LLC | 63,000 | $857,430 | 0.59% |
| Integral Health Asset Management, LLC | 180,000 | $2,449,800 | 0.49% |
| 683 Capital Management, LLC | 480,000 | $6,532,800 | 0.49% |